Nkarta, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
NKTX Nasdaq 2834 www.nkartatx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Nkarta, Inc.

We Think Nkarta (NASDAQ:NKTX) Needs To Drive Business Growth Carefully - Dec 4th, 2025 5:24 am
Nkarta to Participate in Evercore Healthcare Conference - Dec 2nd, 2025 5:09 am
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights - Nov 10th, 2025 2:01 pm
Nkarta to Participate in November Investor Conferences - Oct 30th, 2025 11:14 am
Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies | DelveInsight - Oct 22nd, 2025 3:31 pm
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - Oct 22nd, 2025 8:07 am
Nkarta to Participate in a September Investor Conference - Sep 2nd, 2025 6:01 am
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - Aug 12th, 2025 2:01 pm
Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - Jul 23rd, 2025 6:01 am
Will Nkarta (NASDAQ:NKTX) Spend Its Cash Wisely? - Jun 27th, 2025 5:04 am
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus - Jun 6th, 2025 6:52 am
Nkarta (NKTX) Moves to Buy: Rationale Behind the Upgrade - May 19th, 2025 10:00 am
Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space - May 15th, 2025 1:46 pm
Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights - May 14th, 2025 2:01 pm
Nkarta (NKTX) Upgraded to Buy: Here's Why - Apr 14th, 2025 10:00 am
Nkarta to Participate in an April Investor Conference - Apr 1st, 2025 6:01 am
Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy - Mar 27th, 2025 4:55 am
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - Mar 26th, 2025 2:01 pm
Nkarta (NKTX) Loses -33.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Mar 20th, 2025 7:35 am
Nkarta (NKTX) Loses -32.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Mar 19th, 2025 7:35 am